Target Name: PYROXD1
NCBI ID: G79912
Review Report on PYROXD1 Target / Biomarker Content of Review Report on PYROXD1 Target / Biomarker
PYROXD1
Other Name(s): PYRD1_HUMAN | Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (isoform 1) | pyridine nucleotide-disulphide oxidoreductase domain 1 | Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 | FLJ22028 | Pyridine nucleotide-disulphide oxidoreductase domain 1, transcript variant 1 | MFM8 | PYROXD1 variant 1

Discovering The Potential Drug Target and Biomarker PYRD1

Pyroxidin-1 (PYRD1) is a protein that is expressed in various tissues throughout the body, including the lungs, heart, kidneys, and liver. It is a potent antioxidant that protects cells from damage caused by free radicals, which are unstable molecules that can be produced by cellular processes that are gone wrong.

PYRD1 is a member of the superfamily of NAD+-dependent enzymes, which are involved in a variety of cellular processes that are critical for growth, development, and survival. One of the well-known functions of these enzymes is their role in the production of reactive oxygen species (ROS), which can cause damage to cellular components and contribute to a variety of diseases, including cancer, neurodegenerative diseases, and aging.

Recent studies have identified PYRD1 as a potential drug target and biomarker for a variety of diseases. In this article, we will explore the biology and function of PYRD1, with a focus on its potential as a drug target and biomarker.

PYRD1 biology and function

PYRD1 is a 21-kDa protein that is expressed in a variety of tissues throughout the body, including the lungs, heart, kidneys, and liver. It is highly conserved, with only a single exception at its amino acid acidity. PYRD1 is associated with a variety of cellular processes that are critical for growth, development, and survival, including the production of reactive oxygen species (ROS), the detoxification of xenobiotics, and the regulation of cellular signaling pathways.

PYRD1 is a member of the superfamily of NAD+-dependent enzymes, which are involved in a variety of cellular processes that are critical for growth, development, and survival. One of the well-known functions of these enzymes is their role in the production of reactive oxygen species (ROS), which can cause damage to cellular components and contribute to a variety of diseases, including cancer, neurodegenerative diseases, and aging.

PYRD1 has been shown to play a critical role in the production of ROS. ROS are unstable molecules that can be produced by cellular processes that are gone wrong, such as the metabolism of fatty acids, the production of reactive oxygen species (ROS), or the damage caused by UV radiation. PYRD1 is involved in the production of ROS by activating the NAD+-dependent enzyme superfamily 1 (NAD+-dependent enzymes), which includes a variety of enzymes involved in the production of ROS.

In addition to its role in the production of ROS, PYRD1 is also involved in the regulation of cellular signaling pathways. It has been shown to play a critical role in the detoxification of xenobiotics, which are a variety of molecules that can cause harm to cellular components. This function of PYRD1 is important for maintaining cellular homeostasis and preventing the accumulation of harmful substances in the body.

PYRD1 as a drug target

PYRD1 has been identified as a potential drug target for a variety of diseases. Its involvement in the production of ROS and its role in the regulation of cellular signaling pathways make it an attractive target for compounds that can modulate these processes. In addition, its conserved The only exception to this is nature and the makes it a very attractive target.

One of the most promising strategies for targeting PYRD1 is the use of small molecules that can modulate its activity.

Protein Name: Pyridine Nucleotide-disulphide Oxidoreductase Domain 1

Functions: Probable FAD-dependent oxidoreductase; involved in the cellular oxidative stress response (PubMed:27745833). Required for normal sarcomere structure and muscle fiber integrity (By similarity)

The "PYROXD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PYROXD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PYROXD2 | Pyruvate Dehydrogenase Complex | Pyruvate dehydrogenase kinase | Pyruvate Kinase | PYY | PYY2 | PZP | QARS1 | QDPR | QKI | QPCT | QPCTL | QPRT | QRFP | QRFPR | QRICH1 | QRICH2 | QRSL1 | QSER1 | QSOX1 | QSOX2 | QTRT1 | QTRT2 | Queuine tRNA-ribosyltransferase | R-Spondin | R3HCC1 | R3HCC1L | R3HDM1 | R3HDM2 | R3HDM4 | R3HDML | R3HDML-AS1 | RAB GTPase | RAB10 | RAB11A | RAB11AP2 | RAB11B | RAB11B-AS1 | RAB11FIP1 | RAB11FIP2 | RAB11FIP3 | RAB11FIP4 | RAB11FIP5 | RAB12 | RAB13 | RAB14 | RAB15 | RAB17 | RAB18 | RAB19 | RAB1A | RAB1B | RAB20 | RAB21 | RAB22A | RAB23 | RAB24 | RAB25 | RAB26 | RAB27A | RAB27B | RAB28 | RAB29 | RAB2A | RAB2B | RAB3 GTPase activating protein | RAB30 | RAB30-DT | RAB31 | RAB32 | RAB33A | RAB33B | RAB34 | RAB35 | RAB36 | RAB37 | RAB38 | RAB39A | RAB39B | RAB3A | RAB3B | RAB3C | RAB3D | RAB3GAP1 | RAB3GAP2 | RAB3IL1 | RAB3IP | RAB40A | RAB40AL | RAB40B | RAB40C | RAB41 | RAB42 | RAB42P1 | RAB43 | RAB43P1 | RAB44 | RAB4A | RAB4B | RAB4B-EGLN2